Skip to main content
. Author manuscript; available in PMC: 2012 Oct 1.
Published in final edited form as: J Cardiovasc Transl Res. 2011 Aug 11;4(5):631–643. doi: 10.1007/s12265-011-9292-0

Figure 1. Overall scheme for proposed GlcNAc-mediated drug delivery system.

Figure 1

(a) Decoration of drug-loaded polymeric nanoparticle with GlcNAc should provide a mechanism whereby therapeutics may be delivered intracellularly to CMs. (b) The particle will be composed of the acid-labile poly(cyclohexane-1,4-diyl acetone dimethylene ketal) (PCADK). Once internalized, the particle will degrade into the biocompatible products acetone and cyclohexanedimethanol.